Track topics on Twitter Track topics that are important to you
Nouryon has entered into an agreement to buy J.M. Huber’s carboxymethyl cellulose (CMC) business, continuing its plans to accelerate growth. The transaction includes a manufacturing plant and an advanced R&D facility in Äänekoski, Finland. Around 240 employees will transfer to Nouryon on completion, which is expected in the second quarter of 2020, subject to regulatory approvals.
Original Article: Nouryon Buys J.M. Huber’s CMC BusinessNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...